Patent ID: 9585889
Date: 2017-03-07
CPC Classifications: A61K,A61P,C07D

Claim:
1. A method for treating systemic lupus erythematosus or lupus nephritis, comprising administering to a patient in need thereof an effective amount of a compound or a salt thereof, which is selected from the group consisting of: 6-{6-[2-(1-ethylpiperidin-4-yl}ethoxy]-5-(trifluoromethyl)pyridin-3-yl}-9-methyl-9H-purine-2-carbonitrile or a salt thereof; and 4-{6-[2-(1-ethylpiperidin-4-yl)ethoxy]-5-(trifluoromethyl)pyridin-3-yl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile or a salt thereof.